Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of VINLAZINE 75 vs EFEXOR XR under fed conditions
TCTR20260511011Phase 1Not yet recruiting
- Sponsor
- Government Pharmaceutical Organization
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of venlafaxine in major depressive disorder (MDD) (2 arms), sponsored by Government Pharmaceutical Organization. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20260511011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260511011.